This Sports Tech Stock Slumps 50% as Fund Cuts Stake
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
What To Consider For A 20 Year Retirement Plan
Creating a 20 year retirement plan involves several key considerations. Understand what factors to evaluate for a stable financial future.
25,821 articles
President Jinping Promised China: Boeing Backlog Upside
A high-stakes order from China could reshape Boeing’s revenue trajectory. Here’s how to think about the stock in 2026...
Cognyte (CGNT) 2027 Earnings Outlook for Investors
As Cognyte readies its Q1 2027 earnings report, investors want clarity on growth, margins, and cash flow. This guide ...
Bark (BARK) 2026 Earnings: Investor Guide and Outlook
Bark is shaping its path in a competitive pet market. This guide breaks down what to expect in bark (bark) 2026 earni...
Lemonade Betting Everything Insurance: AI-Driven Bet
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...
Reasons Lilly Stock Like There’s No Tomorrow: A Bold Buy
Seeking a stock with growth, resilience, and optionality? This article lays out three strong reasons to consider Lill...
Vericel (VCEL) 2025 Earnings: A Practical Investor Guide
A practical, investor-focused guide to vericel (vcel) 2025 earnings. Learn how revenue, margins, and milestones could...
Reasons Berkshire Hathaway Stock: Two Compelling Bets
Two compelling reasons berkshire hathaway stock could shine in any market. This piece breaks down the moat, cash flow...
Better Space Stock: Spacemobile vs Rocket Lab Investing Guide
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
Intuitive Surgical Stock: Buy, Hold, or Sell? A Deep Dive
Investors wonder whether Intuitive Surgical stock is worth the risk in today’s market. This comprehensive guide weigh...
This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status